Difference between revisions of "Fibrinogen gamma chain (TG2)"
m |
m |
||
| Line 2: | Line 2: | ||
! {{infobox header}}| '''{{PAGENAME}}''' | ! {{infobox header}}| '''{{PAGENAME}}''' | ||
|- | |- | ||
| − | | align="center" colspan="2" bgcolor="#ffffff" | [[Image: | + | | align="center" colspan="2" bgcolor="#ffffff" | [[Image:Fibrinogen.JPG|200px|{{PAGENAME}}]] |
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
Revision as of 12:14, 30 August 2007
| Template:Infobox header| Fibrinogen gamma chain (TG2) | |
|---|---|
| |
| Substrate peptide name | Fibrinogen gamma chain |
| Synonyms | - |
| Determination type | In vitro |
| Source | Homo sapiens |
| Subcellular localization | Extracellular; plasma |
| Swissprot ID | P02679 |
| Reactive glutamines | Q398 |
| Reactive lysines | K406 |
| Substrate sequence | TIGEGQQHHLGGAKQVRPE |
| Structure | 1FID |
| Surface accessibility | ASAView pdf
ASAView txt |
| Disorder prediction | IUPred |
| Reference | PMID:2902081 |
| Notes | Q145, Q195, Q239, Q311 are minor substrate sites considering modification by TG2 |
| Template:Infobox header | | |
